These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2248955)

  • 61. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
    Hoffman M; Monroe DM; Roberts HR
    Blood; 1994 Jan; 83(1):38-42. PubMed ID: 8274750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
    Liebman HA; Furie BC; Furie B
    J Biol Chem; 1987 Jun; 262(16):7605-12. PubMed ID: 3108254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemical cross-linking of activated coagulation factor VII with soluble tissue factor: calcium ions are not essential for full amidolytic activity of the factor VIIa-tissue factor complex after complex formation.
    Miyata T; Funatsu A; Kato H
    J Biochem; 1995 Apr; 117(4):836-44. PubMed ID: 7592547
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
    Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The evaluation of complex-dependent alterations in human factor VIIa.
    Lawson JH; Butenas S; Mann KG
    J Biol Chem; 1992 Mar; 267(7):4834-43. PubMed ID: 1537862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.
    Mertens K; Cupers R; Van Wijngaarden A; Bertina RM
    Biochem J; 1984 Nov; 223(3):599-605. PubMed ID: 6334516
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tissue factor: regulation of activity by flow and phospholipid surfaces.
    Andree HA; Nemerson Y
    Blood Coagul Fibrinolysis; 1995 May; 6(3):189-97. PubMed ID: 7654932
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
    Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The local phospholipid environment modulates the activation of blood clotting.
    Shaw AW; Pureza VS; Sligar SG; Morrissey JH
    J Biol Chem; 2007 Mar; 282(9):6556-63. PubMed ID: 17200119
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Flow as a regulator of the activation of factor X by tissue factor.
    Gemmell CH; Turitto VT; Nemerson Y
    Blood; 1988 Oct; 72(4):1404-6. PubMed ID: 3262388
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
    Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
    Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A numerical analysis of factor X activation in the presence of tissue factor--factor VIIa complex in a flow reactor.
    Gir S; Slack SM; Turitto VT
    Ann Biomed Eng; 1996; 24(3):394-9. PubMed ID: 8734060
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Kinetics of the activation of human prothrombin by human coagulation factor Xa. Initial rate studies in the presence of Ca2+ and phospholipid.
    Kosow DP; Orthner CL
    J Biol Chem; 1979 Oct; 254(19):9448-52. PubMed ID: 489543
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms.
    Wolberg AS; Monroe DM; Roberts HR; Hoffman MR
    Blood Coagul Fibrinolysis; 1999 Jun; 10(4):201-10. PubMed ID: 10390120
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein.
    Kondo S; Noguchi M; Funakoshi T; Fujikawa K; Kisiel W
    Thromb Res; 1987 Nov; 48(4):449-59. PubMed ID: 2965430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX.
    Bajaj SP; Rapaport SI; Russell WA
    Biochemistry; 1983 Aug; 22(17):4047-53. PubMed ID: 6604546
    [No Abstract]   [Full Text] [Related]  

  • 78. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II.
    Carson SD
    J Biol Chem; 1987 Jan; 262(2):718-21. PubMed ID: 3100517
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma.
    Morrison SA; Jesty J
    Blood; 1984 Jun; 63(6):1338-47. PubMed ID: 6722352
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cleavage and activation of human factor IX by serine proteases.
    Enfield DL; Thompson AR
    Blood; 1984 Oct; 64(4):821-31. PubMed ID: 6383497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.